Overview

Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are: 1. Diet + exercise program. 2. Rosiglitazone treatment. 3. A combination treatment of diet + exercise program and rosiglitazone.
Phase:
N/A
Details
Lead Sponsor:
St. Luke's-Roosevelt Hospital Center
Treatments:
Insulin
Insulin, Globin Zinc
Rosiglitazone